Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03204942Completed
Randomised, single-blind trial (3 arms), sponsored by National Cancer Institute. Primary endpoints: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 at 3 months, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases 22 at 3 months and 2 more. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03204942.